(CXW) CoreCivic - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US21871N1019
Stock: Correctional Facilities, Reentry Centers, Real Estate
Total Rating 40
Risk 57
Buy Signal -0.63
| Risk 5d forecast | |
|---|---|
| Volatility | 38.4% |
| Relative Tail Risk | -13.8% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.15 |
| Alpha | -17.61 |
| Character TTM | |
|---|---|
| Beta | 0.432 |
| Beta Downside | 0.604 |
| Drawdowns 3y | |
|---|---|
| Max DD | 32.62% |
| CAGR/Max DD | 0.69 |
EPS (Earnings per Share)
Revenue
Description: CXW CoreCivic March 05, 2026
CoreCivic Inc. (CXW) operates correctional, detention, and residential reentry facilities across the United States. The companys business model involves partnerships with government entities to manage these facilities, a common practice in the private corrections sector.
CXWs operations are divided into three segments: CoreCivic Safety, CoreCivic Community, and CoreCivic Properties. These segments provide services including facility management, rehabilitation programs, and government real estate solutions. Rehabilitation programs offered include educational, vocational, and substance abuse treatment, aiming to address recidivism.
Understanding the nuances of private correctional facility operations can be further explored on platforms like ValueRay for comprehensive analysis.
Headlines to watch out for
- Government contract renewals and new awards
- Inmate population levels and utilization rates
- Operating costs for facility management
- Regulatory changes impacting private corrections
- Interest rate fluctuations affecting property segment
Piotroski VR‑10 (Strict, 0-10) 6.0
| Net Income: 116.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -5.10 > 1.0 |
| NWC/Revenue: 10.95% < 20% (prev 8.36%; Δ 2.59% < -1%) |
| CFO/TA 0.06 > 3% & CFO 194.6m > Net Income 116.5m |
| Net Debt (1.11b) to EBITDA (348.3m): 3.18 < 3 |
| Current Ratio: 1.66 > 1.5 & < 3 |
| Outstanding Shares: last quarter (104.0m) vs 12m ago -6.29% < -2% |
| Gross Margin: 23.46% > 18% (prev 0.22%; Δ 2323 % > 0.5%) |
| Asset Turnover: 71.46% > 50% (prev 66.91%; Δ 4.55% > 0%) |
| Interest Coverage Ratio: 3.53 > 6 (EBITDA TTM 348.3m / Interest Expense TTM 62.2m) |
Altman Z'' 0.77
| A: 0.07 (Total Current Assets 611.1m - Total Current Liabilities 368.9m) / Total Assets 3.26b |
| B: -0.04 (Retained Earnings -123.5m / Total Assets 3.26b) |
| C: 0.07 (EBIT TTM 219.4m / Avg Total Assets 3.09b) |
| D: -0.07 (Book Value of Equity -122.5m / Total Liabilities 1.85b) |
| Altman-Z'' Score: 0.77 = B |
Beneish M -2.57
| DSRI: 1.37 (Receivables 446.2m/288.7m, Revenue 2.21b/1.96b) |
| GMI: 0.95 (GM 23.46% / 22.23%) |
| AQI: 1.22 (AQ_t 0.16 / AQ_t-1 0.13) |
| SGI: 1.13 (Revenue 2.21b / 1.96b) |
| TATA: -0.02 (NI 116.5m - CFO 194.6m) / TA 3.26b) |
| Beneish M-Score: -2.57 (Cap -4..+1) = A |
What is the price of CXW shares?
As of March 11, 2026, the stock is trading at USD 17.72 with a total of 896,605 shares traded.
Over the past week, the price has changed by -3.38%, over one month by -5.19%, over three months by -4.68% and over the past year by -6.74%.
Over the past week, the price has changed by -3.38%, over one month by -5.19%, over three months by -4.68% and over the past year by -6.74%.
Is CXW a buy, sell or hold?
CoreCivic has received a consensus analysts rating of 5.00.
Therefore, it is recommended to buy CXW.
- StrongBuy: 4
- Buy: 0
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CXW price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 30 | 69.3% |
| Analysts Target Price | 30 | 69.3% |
CXW Fundamental Data Overview March 10, 2026
P/E Trailing = 16.7222
P/E Forward = 11.9617
P/S = 0.8542
P/B = 1.2557
P/EG = 1.0611
Revenue TTM = 2.21b USD
EBIT TTM = 219.4m USD
EBITDA TTM = 348.3m USD
Long Term Debt = 1.21b USD (from longTermDebt, last quarter)
Short Term Debt = 15.7m USD (from shortTermDebt, last quarter)
Debt = 1.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.11b USD (from netDebt column, last quarter)
Enterprise Value = 3.01b USD (1.89b + Debt 1.22b - CCE 97.9m)
Interest Coverage Ratio = 3.53 (Ebit TTM 219.4m / Interest Expense TTM 62.2m)
EV/FCF = 55.80x (Enterprise Value 3.01b / FCF TTM 54.0m)
FCF Yield = 1.79% (FCF TTM 54.0m / Enterprise Value 3.01b)
FCF Margin = 2.44% (FCF TTM 54.0m / Revenue TTM 2.21b)
Net Margin = 5.27% (Net Income TTM 116.5m / Revenue TTM 2.21b)
Gross Margin = 23.46% ((Revenue TTM 2.21b - Cost of Revenue TTM 1.69b) / Revenue TTM)
Gross Margin QoQ = 22.20% (prev 22.55%)
Tobins Q-Ratio = 0.92 (Enterprise Value 3.01b / Total Assets 3.26b)
Interest Expense / Debt = 1.46% (Interest Expense 17.8m / Debt 1.22b)
Taxrate = 26.83% (9.73m / 36.3m)
NOPAT = 160.5m (EBIT 219.4m * (1 - 26.83%))
Current Ratio = 1.66 (Total Current Assets 611.1m / Total Current Liabilities 368.9m)
Debt / Equity = 0.87 (Debt 1.22b / totalStockholderEquity, last quarter 1.41b)
Debt / EBITDA = 3.18 (Net Debt 1.11b / EBITDA 348.3m)
Debt / FCF = 20.54 (Net Debt 1.11b / FCF TTM 54.0m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.77% (Net Income 116.5m / Total Assets 3.26b)
RoE = 8.00% (Net Income TTM 116.5m / Total Stockholder Equity 1.46b)
RoCE = 8.24% (EBIT 219.4m / Capital Employed (Equity 1.46b + L.T.Debt 1.21b))
RoIC = 6.36% (NOPAT 160.5m / Invested Capital 2.52b)
WACC = 4.98% (E(1.89b)/V(3.11b) * Re(7.51%) + D(1.22b)/V(3.11b) * Rd(1.46%) * (1-Tc(0.27)))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.82%
[DCF] Terminal Value 87.05% ; FCFF base≈111.6m ; Y1≈120.3m ; Y5≈148.1m
[DCF] Fair Price = 33.51 (EV 4.38b - Net Debt 1.11b = Equity 3.27b / Shares 97.7m; r=5.90% [WACC]; 5y FCF grow 8.85% → 2.90% )
EPS Correlation: 28.64 | EPS CAGR: 14.97% | SUE: 0.45 | # QB: 0
Revenue Correlation: 84.35 | Revenue CAGR: 7.97% | SUE: 1.42 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.40 | Chg7d=+0.000 | Chg30d=+0.005 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=1.61 | Chg7d=+0.000 | Chg30d=+0.033 | Revisions Net=+2 | Growth EPS=+46.7% | Growth Revenue=+15.4%
EPS next Year (2027-12-31): EPS=2.34 | Chg7d=+2.340 | Chg30d=+2.340 | Revisions Net=+0 | Growth EPS=+45.0% | Growth Revenue=+6.2%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 7.9% - Earnings Yield 6.0%)
[Growth] Growth Spread = +14.9% (Analyst 16.9% - Implied 2.0%)
P/E Forward = 11.9617
P/S = 0.8542
P/B = 1.2557
P/EG = 1.0611
Revenue TTM = 2.21b USD
EBIT TTM = 219.4m USD
EBITDA TTM = 348.3m USD
Long Term Debt = 1.21b USD (from longTermDebt, last quarter)
Short Term Debt = 15.7m USD (from shortTermDebt, last quarter)
Debt = 1.22b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.11b USD (from netDebt column, last quarter)
Enterprise Value = 3.01b USD (1.89b + Debt 1.22b - CCE 97.9m)
Interest Coverage Ratio = 3.53 (Ebit TTM 219.4m / Interest Expense TTM 62.2m)
EV/FCF = 55.80x (Enterprise Value 3.01b / FCF TTM 54.0m)
FCF Yield = 1.79% (FCF TTM 54.0m / Enterprise Value 3.01b)
FCF Margin = 2.44% (FCF TTM 54.0m / Revenue TTM 2.21b)
Net Margin = 5.27% (Net Income TTM 116.5m / Revenue TTM 2.21b)
Gross Margin = 23.46% ((Revenue TTM 2.21b - Cost of Revenue TTM 1.69b) / Revenue TTM)
Gross Margin QoQ = 22.20% (prev 22.55%)
Tobins Q-Ratio = 0.92 (Enterprise Value 3.01b / Total Assets 3.26b)
Interest Expense / Debt = 1.46% (Interest Expense 17.8m / Debt 1.22b)
Taxrate = 26.83% (9.73m / 36.3m)
NOPAT = 160.5m (EBIT 219.4m * (1 - 26.83%))
Current Ratio = 1.66 (Total Current Assets 611.1m / Total Current Liabilities 368.9m)
Debt / Equity = 0.87 (Debt 1.22b / totalStockholderEquity, last quarter 1.41b)
Debt / EBITDA = 3.18 (Net Debt 1.11b / EBITDA 348.3m)
Debt / FCF = 20.54 (Net Debt 1.11b / FCF TTM 54.0m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 3.77% (Net Income 116.5m / Total Assets 3.26b)
RoE = 8.00% (Net Income TTM 116.5m / Total Stockholder Equity 1.46b)
RoCE = 8.24% (EBIT 219.4m / Capital Employed (Equity 1.46b + L.T.Debt 1.21b))
RoIC = 6.36% (NOPAT 160.5m / Invested Capital 2.52b)
WACC = 4.98% (E(1.89b)/V(3.11b) * Re(7.51%) + D(1.22b)/V(3.11b) * Rd(1.46%) * (1-Tc(0.27)))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -100.0 | Cagr: -4.82%
[DCF] Terminal Value 87.05% ; FCFF base≈111.6m ; Y1≈120.3m ; Y5≈148.1m
[DCF] Fair Price = 33.51 (EV 4.38b - Net Debt 1.11b = Equity 3.27b / Shares 97.7m; r=5.90% [WACC]; 5y FCF grow 8.85% → 2.90% )
EPS Correlation: 28.64 | EPS CAGR: 14.97% | SUE: 0.45 | # QB: 0
Revenue Correlation: 84.35 | Revenue CAGR: 7.97% | SUE: 1.42 | # QB: 3
EPS next Quarter (2026-06-30): EPS=0.40 | Chg7d=+0.000 | Chg30d=+0.005 | Revisions Net=+0 | Analysts=3
EPS current Year (2026-12-31): EPS=1.61 | Chg7d=+0.000 | Chg30d=+0.033 | Revisions Net=+2 | Growth EPS=+46.7% | Growth Revenue=+15.4%
EPS next Year (2027-12-31): EPS=2.34 | Chg7d=+2.340 | Chg30d=+2.340 | Revisions Net=+0 | Growth EPS=+45.0% | Growth Revenue=+6.2%
[Analyst] Revisions Ratio: +0.00 (1 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 2.0% (Discount Rate 7.9% - Earnings Yield 6.0%)
[Growth] Growth Spread = +14.9% (Analyst 16.9% - Implied 2.0%)